<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Acta Myol</journal-id>
      <journal-id journal-id-type="publisher-id">Pacini</journal-id>
      <journal-title-group>
        <journal-title>Acta Myologica</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1128-2460</issn>
      <issn pub-type="epub">1128-2460</issn>
      <publisher>
        <publisher-name>Pacini Editore SpA</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21842595</article-id>
      <article-id pub-id-type="pmc">3185826</article-id>
      <article-id pub-id-type="publisher-id">Pacini</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Right ventricular obstructive hypertrophic
cardiomyopathy in primary Myo-Adenylate
Deaminase Deficiency</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>DE GREGORIO</surname>
            <given-names>C.</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MORABITO</surname>
            <given-names>G.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MUSUMECI</surname>
            <given-names>O.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>DONATO</surname>
            <given-names>R.</given-names>
          </name>
          <xref ref-type="aff" rid="A2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>TOSCANO</surname>
            <given-names>A.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff>Clinical and Experimental Department of Medicine and Pharmacology;</aff>
      <aff id="A1"><label>1</label> Department of Neurosciences, Psichiatry
and Anesthesiology;</aff>
      <aff id="A2"><label>2</label> Department of Radiological Sciences, Messina University Hospital, Messina, Italy</aff>
      <author-notes>
        <corresp id="COR1">Address for correspondence: Cesare de Gregorio, Dipartimento Clinico-Sperimentale di Medicina e Farmacologia, Unit&#xE0; Operativa
di Cardiologia, Policlinico Universitario di Messina, viale Gazzi, 98125 Messina, Italy. Tel/Fax +39 090 2213531. E-mail: <email xlink:href="cdegregorio@unime.it">cdegregorio@unime.it</email>; <email xlink:href="cesaredegregorio@tiscali.it">cesaredegregorio@tiscali.it</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2011</year>
      </pub-date>
      <volume>30</volume>
      <issue>1</issue>
      <fpage>46</fpage>
      <lpage>48</lpage>
      <permissions>
        <copyright-statement>The journal and the individual contributions contained in it are protected by the copyright of Gaetano Conte Academy, Naples, Italy
</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License, which permits for noncommercial use, distribution, and reproduction in any digital medium, provided the original work is properly cited and is not altered in any way. For details, please refer to <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link></license-p>
        </license>
      </permissions>
      <abstract>
        <p>MyoAdenylate Deaminase Deficiency (MADD) is a relatively common metabolic disorder of the skeletal muscle. Patients with MADD usually show an impaired bioenergetic production and a clinical spectrum with either exercise-induced muscle pain, fatigue and/or rhabdomyolysis.</p>
        <p>Left ventricular hypertrophy as well as other types of cardiac involvement have been reported in patients with primary MADD.</p>
        <p>We describe herein a case of a 61-year-old woman with biochemical and genetic evidence of Myo-Adenylate Deaminase deficiency, in whom we found a right ventricular hypertrophic cardiomyopathy leading to severe outflow tract dynamic obstruction.</p>
      </abstract>
      <kwd-group>
        <title>Key words</title>
        <kwd>Echocardiography</kwd>
        <kwd>Myo-Adenylate Deaminase deficiency</kwd>
        <kwd>neuromuscular disorders</kwd>
        <kwd>right ventricular disease</kwd>
        <kwd>right
ventricular hypertrabeculation</kwd>
        <kwd>right ventricular hypertrophic cardiomyopathy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="S1">
      <title>Introduction</title>
      <p>Myo-Adenylate Deaminase deficiency (MADD) is a relatively common metabolic disorder of the skeletal muscle firstly described in 1978 (<xref ref-type="bibr" rid="R01">1</xref>). The enzyme is one of the most active in the purine nucleotide cycle, playing the adenosine-5-monophosphate deamination and maintaining the high adenosine-5-triphosphate/-diphosphate/- monophosphate ratio necessary for the bionergetic metabolism of the working muscle.</p>
      <p>Because of the variety of genetic expression of such mutant alleles, the syndrome ranges from asymptomatic carriers to patients showing exercise-induced muscle pain, fatigue, intolerance to exercise, and/or rhabdomyolysis (rare) (<xref ref-type="bibr" rid="R02">2</xref>-<xref ref-type="bibr" rid="R06">6</xref>).</p>
      <p>A morphofunctional involvement of the left ventricle (LV, left ventricular), chiefly consisting of myocardial	hypertrophy or hypertrabeculation (HT), has been described in some MADD patients (<xref ref-type="bibr" rid="R07">7</xref>, <xref ref-type="bibr" rid="R08">8</xref>).</p>
      <p>We report a peculiar case of right ventricular (RV, right ventricle) hypertrophic cardiomyopathy leading to severe dynamic obstruction across the outflow tract.</p>
    </sec>
    <sec id="S2">
      <title>Case report</title>
      <p>A 61-year-old woman presented with a long-lasting history of diffuse myalgias, cramps at lower limbs, fatigue and exercise intolerance. Her family history was unremarkable for neuromuscular disorders, heart diseases and conventional cardiovascular risk factors.</p>
      <p>Neurological examination showed mild proximal muscle weakness, more pronounced at lower limbs. Laboratory measurements showed mild CK elevation (397 U/l; reference range, &lt; 200 U/l). Electromyography was unremarkable, whereas muscle biopsy revealed unspecific morphological alterations, but totally absent histochemical staining for MAD. Biochemical study on muscle homogenate also evidenced a virtual absence of MAD activity. Analysis of adenosin-monophosphate-deaminase 1 (AMPD-1) gene identified the common mutation C34T in an homozygous state, which confirmed the diagnosis of MADD.</p>
      <p>As routinely scheduled in our neuromuscular patients, she was referred to the cardiology department for heart evaluation.</p>
      <p>Physical examination revealed resting heart rate of 75 bpm and sitting blood pressure of 135/80 mm Hg. Intense systolic murmur (Levine grade 4) was electively heard on the pulmonary valve.</p>
      <p>Resting ECG (<xref ref-type="fig" rid="F1">Fig. 1</xref>) revealed sinus rhythm (75 bpm), normal atrio-ventricular conduction time (180 ms), right bundle branch block (QRS duration &lt; 120 ms), high S-wave voltage in leads V4-5 and negative T-waves in leads V1-5, with no serious arrhythmias at 24-hour ECG monitoring.</p>
      <fig fig-type="Halftone" id="F1" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>Twelve-lead resting electrocardiogram.</p>
        </caption>
        <graphic xlink:href="1128-2460-30-46-g001"/>
      </fig>
      <p>Transthoracic echocardiography showed normal LV morphofunctional indices at rest, but concentric RV hypertrophy (free-wall diastolic thickness 8 mm). Global systolic function was preserved (ejection fraction &#x2265; 0.60) in both ventricles, with normal fractional shortening. Tricuspid and mitral annulus plane systolic excursion were 20 and 17 mm, respectively. Possible endomyocardial HT was seen in the RV outflow tract (<xref ref-type="fig" rid="F2">Fig. 2, A-B</xref>) to be associated to a muscular obstruction leading to severe dynamic gradient throughout the outflow tract (peak value 60-70 mm Hg) (<xref ref-type="fig" rid="F2">Fig. 2, C-D</xref>).</p>
      <p>The patient underwent gadolinium-enhanced cardiac magnetic resonance imaging (MRI), which confirmed the RV free wall hypertrophy, but also demonstrated a giant moderator band, both leading to outflow tract occlusion (<xref ref-type="fig" rid="F2">Fig. 2, E-F</xref>). No signs of RV dysplasia or delay enhancement were recognized.</p>
      <fig fig-type="Halftone" id="F2" position="float">
        <label>Figure 2.</label>
        <caption>
          <p>Ultrasound imaging of the right ventricular hypertrophy and hypertrabeculation (panels A and B) causing
severe dynamic obstruction through the outflow tract (panels C and D). Panels E and F show cardiac magnetic resonance
imaging in diastole and systole, respectively. Note the hypertrophy of the basal RV free wall and of the moderator
band (arrows), both leading to a virtual systolic chamber with outflow tract obliteration. LA, left atrium; LV, left ventricle;
RA, right atrium, RV, right ventricle.</p>
        </caption>
        <graphic xlink:href="1128-2460-30-46-g002"/>
      </fig>
    </sec>
    <sec id="S3">
      <title>Discussion</title>
      <p>This report shows a novel RV disease in a MADD patient, chiefly consisting with severe hypertrophy of the free wall and the moderator band. These morphofunctional findings may be similar to those from patients with RV arrhythmogenic dysplasia, but the lack of specific MRI findings, delay enhancement, typical premature ventricular beats, epsilon potentials at ECG and myocardial vacuolations allowed us to exclude that cardiomyopathy (<xref ref-type="bibr" rid="R09">9</xref>, <xref ref-type="bibr" rid="R10">10</xref>).</p>
      <p>Interestingly, prominent trabeculations into the RV, like in our patient, are quite hard to be interpreted properly. In fact, due to its irregular structure, the diagnosis of RV-HT is challenging. The criteria proposed by Jenni et al. (<xref ref-type="bibr" rid="R11">11</xref>) and Stollberger et al. (<xref ref-type="bibr" rid="R12">12</xref>) for LV-HT barely apply to the RV. As recently emphasized by Limongelli et al. (<xref ref-type="bibr" rid="R13">13</xref>) multiple or exaggerated trabeculations can be a normal variant of the RV, and there is no chance for both echocardiography and cardiac MRI to discriminate between the two conditions. Nevertheless, RV-HT has been described in neonatal decompensated hearts (<xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R15">15</xref>).</p>
      <p>The severe RV dynamic obstruction is of clinical concern because of: a) its influence on patient's symptoms (fatigue, breathlessness), b) few chances of reducing the gradient noninvasively.</p>
      <p>In conclusion, although genetic relationships between neurological and cardiological features are not well defined, this report confirms the need for a comprehensive investigation of the heart in MADD patients, bearing in mind that the above described symptoms could be the consequence of undervalued heart failure.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>The Authors are grateful to Dr. Gianluca Di Bella for his comments on cardiac magnetic resonance findings.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R01">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fishbein</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Armbrustmacher</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Myoadenylate
deaminase deficiency: A new disease of muscle</article-title>
          <source>Science</source>
          <year>1978</year>
          <volume>200</volume>
          <fpage>545</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">644316</pub-id>
        </element-citation>
      </ref>
      <ref id="R02">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kar</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Muscle adenylate deaminase deficiency: report
of six new cases</article-title>
          <source>Arch Neurol</source>
          <year>1981</year>
          <volume>38</volume>
          <fpage>279</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="pmid">7224911</pub-id>
        </element-citation>
      </ref>
      <ref id="R03">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fishbein</surname>
              <given-names>WN</given-names>
            </name>
          </person-group>
          <article-title>Primary, secondary, and coincidental types of myoadenylate
deaminase deficiency</article-title>
          <source>Ann Neurol</source>
          <year>1999</year>
          <volume>45</volume>
          <fpage>547</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">10211487</pub-id>
        </element-citation>
      </ref>
      <ref id="R04">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fishbein</surname>
              <given-names>WN</given-names>
            </name>
          </person-group>
          <article-title>Myoadenylate deaminase deficiency: inherited and
acquired forms</article-title>
          <source>Biochem Med</source>
          <year>1985</year>
          <volume>33</volume>
          <fpage>158</fpage>
          <lpage>169</lpage>
          <pub-id pub-id-type="pmid">4004819</pub-id>
        </element-citation>
      </ref>
      <ref id="R05">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toscano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aguennouz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Monici</surname>
              <given-names>MC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Myoadenilate deaminase
deficiency: clinical, histochemical and biochemical studies in
primary and "coincidental" cases</article-title>
          <source>Ital J Biochem</source>
          <year>1997</year>
          <volume>46S</volume>
          <fpage>170</fpage>
          <lpage>174</lpage>
        </element-citation>
      </ref>
      <ref id="R06">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mercelis</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Barsy</surname>
              <given-names>T</given-names>
              <prefix>de</prefix>
            </name>
            <etal/>
          </person-group>
          <article-title>Myoadenylate deaminase
deficiency: absence of correlation with exercise intolerance in 452
muscle biopsies</article-title>
          <source>J Neurol</source>
          <year>1987</year>
          <volume>234</volume>
          <fpage>385</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="pmid">3655841</pub-id>
        </element-citation>
      </ref>
      <ref id="R07">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finsterer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schoser</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Stollberger</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Myoadenylate deaminase
gene mutation associated with left ventricular hypertrabeculation</article-title>
          <source>Acta Cardiol</source>
          <year>2004</year>
          <volume>59</volume>
          <fpage>453</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">15368811</pub-id>
        </element-citation>
      </ref>
      <ref id="R08">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skyllouriotis</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Marx</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bittner</surname>
              <given-names>RE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Myoadenylate deaminase
deficiency, hypertrophic cardiomyopathy and gigantism syndrome</article-title>
          <source>Pediatr Neurol</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>61</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">9308979</pub-id>
        </element-citation>
      </ref>
      <ref id="R09">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcus</surname>
              <given-names>FI</given-names>
            </name>
            <name>
              <surname>McKenna</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Sherrill</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diagnosis of arrhythmogenic
right ventricular cardiomyopathy/dysplasia:
proposed modification of the task force criteria</article-title>
          <source>Circulation</source>
          <year>2010</year>
          <volume>121</volume>
          <fpage>1533</fpage>
          <lpage>1541</lpage>
          <pub-id pub-id-type="pmid">20172911</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bauce</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Basso</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ramazzo</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical profile of four
families with arrhythmogenic right ventricular cardiomyopathy
caused by dominant desmoplakin mutations</article-title>
          <source>Eur Heart J</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>1666</fpage>
          <lpage>1675</lpage>
          <pub-id pub-id-type="pmid">15941723</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jenni</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Oechslin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Echocardiographic and
patho-anatomical characteristics of pathological noncompaction, as
a distinct cardiomyopathy</article-title>
          <source>Heart</source>
          <year>2001</year>
          <volume>86</volume>
          <fpage>666</fpage>
          <lpage>671</lpage>
          <pub-id pub-id-type="pmid">11711464</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stollberger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Finsterer</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Left ventricular hypertrabeculation/ noncompaction</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2004</year>
          <volume>17</volume>
          <fpage>91</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">14712196</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Limongelli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pacileo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Calabr&#xF2;</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Right ventricular hypertrabeculation
associated with double-outlet left ventricle: exaggeration
of a normal pattern or right ventricular cardiomyopathy?</article-title>
          <source>J
Cardiovasc Med</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>193</fpage>
          <lpage>195</lpage>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alehan</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dogan</surname>
              <given-names>OF</given-names>
            </name>
          </person-group>
          <article-title>Right ventricular noncompaction in a neonate
with complex congenital heart disease</article-title>
          <source>Cardiol Young</source>
          <year>2005</year>
          <volume>15</volume>
          <fpage>434</fpage>
          <lpage>436</lpage>
          <pub-id pub-id-type="pmid">16014196</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hruda</surname>
              <given-names>j</given-names>
            </name>
            <name>
              <surname>Sobotka-Plojhar</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Fetter</surname>
              <given-names>WP</given-names>
            </name>
          </person-group>
          <article-title>Transient postnatal heart
failure caused by noncompaction of the right ventricular myocardium</article-title>
          <source>Pediatr Cardiol</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>452</fpage>
          <lpage>454</lpage>
          <pub-id pub-id-type="pmid">16374698</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
